OnCusp Therapeutics Competitors and Similar CompaniesClear all
OnCusp Therapeutics's competitors and similar companies include Seagen, Century Therapeutics, Dendreon and Mallinckrodt Pharmaceuticals.
 OnCusp Therapeutics OnCusp Therapeutics is a biopharmaceutical company that specializes in cancer treatment solutions. |  Seagen Seagen (formerly known as Seattle Genetics) is a biotechnology company that develops and commercializes targeted therapies to treat cancer. |  Century Therapeutics Century Therapeutics is a biotech company that develops therapies to treat cancer. |  Dendreon Dendreon Pharmaceuticals (formerly known as Activated Cell Therapy) is a biopharmaceutical company that engages in the development of immunotherapy. |  Mallinckrodt Pharmaceuticals Mallinckrodt is a business that develops, manufactures, markets and distributes specialty pharmaceutical and biopharmaceutical products and therapies. | |
Founding Date | Founding Date 2021 | Founding Date 1998 | Founding Date 2018 | Founding Date 1992 | Founding Date 1867 |
Type | Type Private | Type Subsidiary | Type Public | Type Subsidiary | Type Private |
Tags | |||||
Locations | Locations New York, US HQ Shanghai, CN Shanghai, CN | Locations Bothell, US HQ Mississauga, CA Hørsholm, DK Rueil Malmaison, FR München, DE Milano, IT Schiphol, NL see more | Locations Philadelphia, US HQ Hamilton, CA Seattle, US | Locations Seal Beach, US HQ Seattle, US Union City, US Tampa, US | Locations Dublin 15, IE HQ Staines, GB Hazelwood, US Webster Groves, US |
Employees | Employees 2519% increase | Employees 3,25622% increase | Employees 107 | Employees 6131% decrease | Employees 3,373 |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $2b (FY, 2022) | Revenue (est.) $109.2m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $1b (FY, 2022) |
Cost of goods | Cost of goods N/A | Cost of goods $410.1m (FY, 2022) | Cost of goods N/A | Cost of goods N/A | Cost of goods $643.5m (FY, 2022) |
Gross profit | Gross profit N/A | Gross profit $1.6b (FY, 2022) | Gross profit N/A | Gross profit N/A | Gross profit $396.2m (FY, 2022) |
Net income | Net income N/A | Net income ($610.3m) (FY, 2022) | Net income ($9.6m) (FY, 2025) | Net income N/A | Net income ($598.3m) (FY, 2022) |
Funding | |||||
Total funding raised | Total funding raised $ 125m | Total funding raised $ 164m | Total funding raised $ 410m | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Seagen
HQ
Bothell, US
Seagen (formerly known as Seattle Genetics) is a biotechnology company that develops and commercializes targeted therapies to treat cancer.
View companyCentury Therapeutics
HQ
Philadelphia, US
Employees
107
Century Therapeutics is a biotech company that develops therapies to treat cancer.
View companyDendreon
HQ
Seal Beach, US
Dendreon Pharmaceuticals (formerly known as Activated Cell Therapy) is a biopharmaceutical company that engages in the development of immunotherapy.
View companyMallinckrodt Pharmaceuticals
HQ
Dublin 15, IE
Employees
3,373
Mallinckrodt is a business that develops, manufactures, markets and distributes specialty pharmaceutical and biopharmaceutical products and therapies.
View company